Washington, U.S. | Xinhua | The U.S. Food and Drug Administration (FDA) on Thursday authorized American pharmaceutical company Merck’s oral antiviral for the treatment of mild-to-moderate COVID-19, the second pill approved for treating COVID-19 following the one from Pfizer. Merck’s pill, called molnupiravir, is authorized to use in adults with positive …
Read More »New ‘100% effective’ Ebola vaccine
Almost a year after the official end of the Ebola outbreak in West Africa, the final results from one of the only Ebola vaccine trials are now in – and they look very promising. This is the only data we have on a vaccine against a virus in the Ebolavirus …
Read More »